Market Research Reports, Business Consulting Services & Analytics

Increase in FDA Approvals of Such Medicines is Further Contributing to the Growth of Pediatrics Medicine Market.

HYDERABAD, TELANGANA, INDIA, November 14, 2022 /EINPresswire.com/ -- IndustryARC, in its latest report, predicts that the Pediatrics Medicine Market size was estimated at $101 billion in 2020, projected to grow at a CAGR of 5.2% during the forecast period 2021-2026. Pediatrics Medicine industry has witnessed huge demand owing to the rising pediatric diseases such as cystic fibrosis, asthma, and other infectious diseases. All pediatricians that deal with pediatric medicine are more concerned with congenital abnormalities, genetic variation and developmental problems. The pediatric medicine market grows significantly as children suffer from respiratory, gastrointestinal, allergic and other chronic diseases owing to their weaker immunity. The report offers a complete analysis of the market, its major segments, growth factors, trends, drivers and challengers, key players and more.

Click here to browse the complete report summary:
https://www.industryarc.com/Research/Pediatrics-Medicine-Market-Research-507060

Key Takeaways:

This IndustryARC report on the Pediatrics Medicine Market highlights the following areas -

1. Geographically, North America Pediatrics Medicine Market held the largest revenue share of 37% in 2020 owing to the region demand.

2. Significant R&D techniques adopted by the key players of the market is one of the major factors supporting global pediatric medicine market.

3. Increase in FDA approvals for pediatric medicine formulations are propelling the market for the Pediatrics Medicine.

Interested in knowing more relevant information? Click here:
https://www.industryarc.com/pdfdownload.php?id=507060

Segmental Analysis:

Pediatrics Medicine Market Segment Analysis – By Type of Medicine: Chronic obstructive pulmonary disease is a major cause of pediatric healthcare burden. Montelukast is used for prophylaxis of asthma from age of 2 years and older than that, where the predominant component is exercise induced broncho-constriction. Autoimmune disorders segment is poised to grow with the fastest CAGR of 5.8% in the forecast period 2021-2026.

Pediatrics Medicine Market Segment Analysis – By Route of Administration: Oral segment accounted for largest revenue market share in 2020. As Oral delivery of medicines is the most preferred route of administration for the pediatric patients owing to its non-invasive form and has less risk of pain.

Pediatrics Medicine Market Segment Analysis – By Geography: The rising number of pediatric cases that are suffering from various respiratory disorders, autoimmune disorders, muscular atrophy, cerebral palsy coupled with adoption of advanced technologies in the U.S. for instance, American Academy of allergy, Asthma & Immunology statistics has estimated that in 2018, more than 40% children in the U.S have allergies thereby rising demand for pediatric medicine is boosting the market in this region.

Competitive Landscape:

The top 5 players in the Pediatrics Medicine industry are -

1. Cipla, Inc.

2. Lupin

3. Pfizer Inc.

4. F. Hoffman-La Roche Ltd

5. Sanofi S.A.

Click on the following link to buy the Pediatrics Medicine Market report:
https://www.industryarc.com/reports/request-quote?id=507060

Why Choose IndustryARC?

IndustryARC is one of the leading market research and consulting firms in the world. It produces over 500 unique market reports annually. If you are looking for a detailed overview of a particular market, you can simply connect with the team at IndustryARC. You can not only buy your preferred market report from the website, but also get personalized assistance on specific reports.

Similar Reports:

A. Pediatric Market
https://www.industryarc.com/Report/1290/pediatric-market-analysis.html

B. Pediatric Supplements Market
https://www.industryarc.com/Report/15129/pediatric-supplements-market.html

Contact Us:
Mr. Venkat Reddy
IndustryARC
Email: sales@industryarc.com
USA: (+1) 970-236-3677, (+1) 815-656-4596
IND: (+91) 40-485-49062

Venkat Reddy
IndustryARC
+ +1 614-588-8538
venkat@industryarc.com
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.